InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Crowley Elizabeth, Vice-Présidente Senior et Responsable de la Conformité des Produits. Director active across 1 company, notably Celldex Therapeutics, Inc.. Aggregated, 5 disclosures have been published. Activity tracked since 1 November 2021. The latest transaction was filed on 14 June 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Elizabeth Crowley serves as Senior Vice President and Chief Product Development Officer at Celldex Therapeutics, Inc. She is responsible for ensuring that the company's products meet regulatory standards. Her expertise is essential in ensuring the safety and efficacy of the products.